Related Experiment Video
Updated: Jun 28, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
19.9K
[Interstitial Lung Disease associated with Connective Tissue Diseases]
1Inselspital Bern Freiburger Str. 3010 Bern.
Therapeutische Umschau. Revue Therapeutique
|April 24, 2024
Summary
Interstitial lung diseases (ILD) linked to connective tissue diseases (CTD) worsen patient outcomes. Early diagnosis and tailored treatments, including immunosuppressants and antifibrotics, are crucial for managing CTD-ILD.
Area of Science:
- Rheumatology
- Pulmonology
- Immunology
Background:
- Interstitial lung diseases (ILD) affect up to one-third of patients with connective tissue diseases (CTD).
- Associated ILD significantly increases morbidity and mortality in conditions like systemic sclerosis and rheumatoid arthritis.
- Thorough evaluation for underlying CTD is vital, even in unclassified ILDs.
Purpose of the Study:
- To outline the diagnostic approach for CTD-ILD.
- To discuss pharmacological treatment strategies for CTD-ILD.
- To emphasize the importance of multidisciplinary decision-making in CTD-ILD management.
Main Methods:
- Comprehensive medical history and physical examination.
- Targeted rheumatological assessment.
- Functional, radiological, laboratory, and potentially invasive diagnostic tests.
Main Results:
- Pharmacological treatments for CTD-ILD differ from other ILDs, often involving glucocorticoids, antimetabolites, and biologics.
- Antifibrotic drugs show efficacy in CTD-ILD.
- Treatment decisions are multifactorial, considering disease specifics, activity, and patient factors.
Conclusions:
- Accurate diagnosis and tailored treatment are essential for improving outcomes in CTD-ILD.
- A multidisciplinary approach optimizes complex treatment decisions for CTD-ILD.
- Early identification and management of CTD-ILD can mitigate significant morbidity and mortality.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
422
06:15Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
864
Related Concept Videos
01:11Introduction to Connective Tissues
9.6K
Connective tissues are one of the four main tissue types in humans that are extensively present in the body. They are characterized by cells embedded in an extracellular matrix (ECM) composed of a ground substance and three main types of protein fibers— collagen, elastic, and reticular fibers. The ground substance of connective tissues can range from a watery and jelly-like consistency to mineralized and hard. The wide variety of cells in the connective tissues include fibroblasts,...
9.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:22Connective Tissue Cell Types
3.2K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.2K
01:17Other Pulmonary Disorders
836
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
836
01:29Pulmonary Tuberculosis I
241
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
241
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K